Sensydia
PrivateLast Round
VC Round
Oct 13, 2026
Total Funding Raised
$7.4M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Sensydia operates in Healthcare & Life Sciences and is based in Los Angeles, California. Its latest recorded funding round was a VC Round in October 2026.
Sensydia is a healthcare technology company that develops a portable, point-of-care hemodynamic measurement device for the treatment and management of heart disease patients, facilitating non-invasive monitoring of critical cardiac metrics to enhance patient outcomes and reduce healthcare costs.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sensydia Comparables
Compare Sensydia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Acorai | 88% | |
| Respirix, Inc. | 82% | |
| NI Medical | 80% |
For institutional investors. Book with your work email.
Sensydia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 13, 2026 | ||||
| Grant | Jun 9, 2025 | ||||
| Grant | Jun 5, 2023 | ||||
| VC Round | May 9, 2023 | ||||
| Series B | Jan 19, 2022 | ||||
VC Round | Jul 23, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Sensydia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Colle Capital | VC Round, Series B |
| Orlando Health Ventures | VC Round |
| National Heart, Lung, and Blood Institute | Grant |
| Frontier Venture Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 13, 2026
$6M round led by Colle Capital.
- May 15, 2026
Monthly visitors increased 41% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingOct 13, 2026
Sensydia receives $6M in an oversubscribed initial financing closing exceeding $6 million, led by Colle Capital Partners with substantial support from Orlando Health Ventures, to fund the ACOUSTIC-1 study and commercial launch preparation in California on Oct 13th '26.
For institutional investors. Book with your work email.
Sensydia Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sensydia's valuation, stock price, and market status.
Is Sensydia a public or private company?
Sensydia is a private company.
What is the current stock price of Sensydia?
Sensydia is a private company, so its shares have no public market price. Caplight tracks Sensydia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sensydia worth (valuation)?
Valuation information for Sensydia is not publicly available.
Can I buy Sensydia stock?
Sensydia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sensydia's last funding round?
Sensydia's most recent funding round was VC Round on October 13, 2026.
Who are the main investors in Sensydia?
Key investors in Sensydia include Colle Capital, Orlando Health Ventures.
Will Sensydia IPO soon?
No public IPO plans have been announced for Sensydia.
How can I track Sensydia secondary market activity?
Caplight tracks bids, offers, and trades in Sensydia's shares on secondary markets.